Subscribe Free
in Maintenance

Dnata awarded UK MHRA certification for Good Distribution Practice

Posted 19 April 2018 · Add Comment

Global air services provider and UK’s leading ground handler, Dnata, has been awarded certification for Good Distribution Practice (GDP) by the UK Medicines and Healthcare Products Regulatory Agency (UK MHRA).

 

The UK MHRA granted Dnata full Wholesaler Dealer Authorisation (WDA) after Dnata completed the organisation’s Good Distribution Programme, while simultaneously investing into cutting-edge pharma handling technology at several of its facilities.

Dnata’s investment includes a sophisticated 24-hour warehouse monitoring system that has the ability to conduct temperature mapping and advise Dnata operators ahead of any deviation in temperature. This, in, turn enables pre-planning, quick response to adapt to adverse weather conditions and assessment of potential transport routes for pharma products.

Temperature mapping is also routinely conducted within Dnata’s facilities in the summer and winter to gauge average temperatures.

This leading-edge technology recently paid dividends when the cold front struck in early March and temperatures across the UK plummeted. Dnata was able to prepare for the severe temperature onslaught, and ensure that all pharmaceuticals handled followed the optimum route, at temperatures that limited the risk of spoilage.

In addition, the company has installed automated handling systems that can store pharmaceuticals at variable temperature ranges.

In order to achieve certification, Dnata was required to either review or make enhancements to its quality systems, operations documentation and facilities management practices – a 12 to 24-month process that it completed in just six months.

“We have invested in pharma-handling facilities across the UK in response to customer demand and in recognition of the growing importance of pharma cold-chain logistics,” said Dnata UK CEO Gary Morgan. 

“With world-class technology already in place at our facilities, the next logical step was to ensure standards compliance and achieve UK MHRA certification.  These initiatives not only demonstrate our ongoing focus on safety and quality, but also reinforce our commitment to our airline customers who operate in the fast-growing pharmaceutical transportation sector. ”

 

* required field

Post a comment

Other Stories
Latest News

Emirates introduces A380 on Riyadh route

Emirates is introducing the first scheduled Airbus A380 service to Riyadh, effective 21 April 2019. Riyadh will be the 51st destination to join the Emirates A380 network.

Rolls-Royce Tay 611-8 engine achieves 10 million flying hours

The Rolls-Royce Tay 611-8 engine, which entered service in 1987, recently reached 10 million flying hours in nearly five million flights.

Airbus will participate at Turkey’s IDEF 2019

Airbus will attend Turkey’s IDEF 2019, 14th International Defence Industry Fair, held in Istanbul from April 30 to May 3.

Export Bahrain partners with Gulf Air Cargo to offer special discounts on cargo exports

Export Bahrain has signed an exclusive partnership with Gulf Air’s Falcon Cargo to provide SMEs in the Kingdom of Bahrain, exporting their goods to the tune of 100 kilograms or above, with special discount of up to 40% on their cargo

Could Al Ain be the UAE’s sleeping superstar?

Al Ain International Airport is poised for growth – cargo is already expanding and the search is on for more passenger traffic, as Alan Dron discovered.

EgyptAir takes delivery of second B787-9 Dreamliner

EgyptAir’s second B787-9 Dreamliner has arrived today at Cairo International Airport. The aircraft is slated to operate flights from Cairo to Frankfurt by April 22nd.

Connect MEIA SK1402010519
See us at
Connect MEIA BT1402010519ACCA19_BT2141218280219